Mia's Feed
Medical News & Research

Innovative AI Technique Illuminates How Gamma-Secretase Targets Molecules in Alzheimer's Disease

Innovative AI Technique Illuminates How Gamma-Secretase Targets Molecules in Alzheimer's Disease

Share this article

A novel AI approach has uncovered the molecular recognition logic of gamma-secretase, an enzyme linked to Alzheimer's disease, unveiling new potential targets and enhancing drug development strategies.

2 min read

Researchers from the German Center for Neurodegenerative Diseases (DZNE), Ludwig-Maximilians-Universität München (LMU), and the Technical University of Munich (TUM) have developed a groundbreaking artificial intelligence (AI) approach to understand how the enzyme gamma-secretase recognizes and interacts with its various targets. Gamma-secretase, an enzyme implicated not only in Alzheimer's disease but also in cancer, is known to cleave over 150 different proteins embedded in cell membranes. Despite its importance, predicting its reaction partners has remained a significant challenge because gamma-secretase does not follow clear sequence patterns, unlike many other proteases.

In their study published in Nature Communications, the team introduced a novel methodology called Comparative Physicochemical Profiling (CPP). This AI-driven approach analyzes the physical and chemical properties of known gamma-secretase substrates to uncover hidden similarities and recognition logic. By integrating biochemical data with explainable AI, the researchers were able to better understand the factors driving molecular recognition by gamma-secretase.

A key finding is that substrates of gamma-secretase share specific physicochemical signatures near the cleavage site, including the ability to adopt multiple conformations, which are crucial for recognition within the cellular membrane environment. Using this method, the team identified 160 proteins as potential new substrates—none of which had been previously linked to gamma-secretase—with eleven already validated experimentally.

This research not only advances our understanding of gamma-secretase's role in neurodegenerative diseases such as Alzheimer's but also provides a versatile framework applicable to other proteases and receptor systems. The insights gained could eventually lead to the development of more targeted drugs with fewer side effects, improving treatments for neurodegenerative and other diseases.

Overall, this innovative use of explainable AI offers a promising new avenue for exploring molecular recognition processes in health and disease, holding potential for significant impact in drug discovery and disease understanding.

Source: https://medicalxpress.com/news/2025-07-ai-method-enzyme-linked-alzheimer.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Proposed Framework to Shield Patients from Risks of High-Impact Brain Implants

A new proposal advocates for a no-fault compensation system to support patients harmed by high-risk brain implants, ensuring safety and justice as neural interface technologies advance.

How Walking 7,000 Steps Daily May Lower Your Cancer Risk

A large UK study shows that walking at least 7,000 steps daily can significantly reduce the risk of developing various types of cancer. Regular movement, even at light intensity, plays a vital role in cancer prevention.

Reinstatement of Hundreds of Laid-Off CDC Employees Marks a Shift in Public Health Workforce

Over 460 CDC employees who were laid off earlier this year are now being reinstated, signaling a shift in federal public health staffing. Learn more about the ongoing impact on CDC programs and operations.

Erythritol's Potential Impact on Brain Blood Vessels and Stroke Risk

New scientific research suggests that erythritol, a popular sugar substitute, may impair brain blood vessel function and elevate stroke risk. Learn about the latest findings on this widely used additive.